Parabilis Medicines, Inc. (PBLS)
NASDAQ: PBLS · Real-Time Price · USD
30.83
+0.48 (1.58%)
At close: Jul 8, 2026, 4:00 PM EDT
30.00
-0.83 (-2.69%)
After-hours: Jul 8, 2026, 7:59 PM EDT

Parabilis Medicines Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Jul '26 Dec '25 Dec '24
3,926--
Enterprise Value
3,650--
Debt / Equity Ratio
0.22-3.551.17
Net Debt / Equity Ratio
-1.13-1.87-0.39
Net Debt / EBITDA Ratio
1.80-0.210.18
Net Debt / FCF Ratio
1.98-0.250.21
Quick Ratio
6.070.492.77
Current Ratio
6.120.522.85
Return on Equity (ROE)
--731.00%-
Return on Assets (ROA)
--80.33%-
Return on Capital Employed (ROCE)
-47.30%-615.30%-104.40%
Buyback Yield / Dilution
--4.59%-
SEC Filings: 10-K · 10-Q